Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 3
2015 4
2016 7
2017 1
2018 3
2019 4
2020 4
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Results by year
Filters applied: . Clear all
Page 1
Curcumin: New Insights into an Ancient Ingredient against Cancer.
Willenbacher E, Khan SZ, Mujica SCA, Trapani D, Hussain S, Wolf D, Willenbacher W, Spizzo G, Seeber A. Willenbacher E, et al. Int J Mol Sci. 2019 Apr 12;20(8):1808. doi: 10.3390/ijms20081808. Int J Mol Sci. 2019. PMID: 31013694 Free PMC article. Review.
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study.
Gisslinger H, Klade C, Georgiev P, Krochmalczyk D, Gercheva-Kyuchukova L, Egyed M, Rossiev V, Dulicek P, Illes A, Pylypenko H, Sivcheva L, Mayer J, Yablokova V, Krejcy K, Grohmann-Izay B, Hasselbalch HC, Kralovics R, Kiladjian JJ; PROUD-PV Study Group. Gisslinger H, et al. Lancet Haematol. 2020 Mar;7(3):e196-e208. doi: 10.1016/S2352-3026(19)30236-4. Epub 2020 Jan 31. Lancet Haematol. 2020. PMID: 32014125 Clinical Trial.
Erratum: Willenbacher, E., et al. Curcumin: New Insights into an Ancient Ingredient against Cancer. Int. J. Mol. Sci. 2019, 20, 1808.
Willenbacher E, Khan SZ, Mujica SCA, Trapani D, Hussain S, Wolf D, Willenbacher W, Spizzo G, Seeber A. Willenbacher E, et al. Int J Mol Sci. 2020 Aug 10;21(16):5725. doi: 10.3390/ijms21165725. Int J Mol Sci. 2020. PMID: 32785029 Free PMC article.
Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera.
Gisslinger H, Zagrijtschuk O, Buxhofer-Ausch V, Thaler J, Schloegl E, Gastl GA, Wolf D, Kralovics R, Gisslinger B, Strecker K, Egle A, Melchardt T, Burgstaller S, Willenbacher E, Schalling M, Them NC, Kadlecova P, Klade C, Greil R. Gisslinger H, et al. Among authors: willenbacher e. Blood. 2015 Oct 8;126(15):1762-9. doi: 10.1182/blood-2015-04-637280. Epub 2015 Aug 10. Blood. 2015. PMID: 26261238 Free PMC article. Clinical Trial.
T cells in multiple myeloma display features of exhaustion and senescence at the tumor site.
Zelle-Rieser C, Thangavadivel S, Biedermann R, Brunner A, Stoitzner P, Willenbacher E, Greil R, Jöhrer K. Zelle-Rieser C, et al. Among authors: willenbacher e. J Hematol Oncol. 2016 Nov 3;9(1):116. doi: 10.1186/s13045-016-0345-3. J Hematol Oncol. 2016. PMID: 27809856 Free PMC article.
Pixantrone demonstrates significant in vitro activity against multiple myeloma and plasma cell leukemia.
Willenbacher E, Jöhrer K, Willenbacher W, Flögel B, Greil R, Kircher B. Willenbacher E, et al. Ann Hematol. 2019 Nov;98(11):2569-2578. doi: 10.1007/s00277-019-03797-6. Epub 2019 Oct 18. Ann Hematol. 2019. PMID: 31628518 Free PMC article. Review.
Clinical challenges in a patient with two BRAF V600E-mutated diseases.
Willenbacher E, Willenbacher W, Loeffler-Ragg J. Willenbacher E, et al. Thorax. 2019 Jun;74(6):620-622. doi: 10.1136/thoraxjnl-2018-212481. Epub 2019 Jan 19. Thorax. 2019. PMID: 30661020 No abstract available.
Short overview on the current standard of treatment in newly diagnosed multiple myeloma.
Willenbacher E, Balog A, Willenbacher W. Willenbacher E, et al. Memo. 2018;11(1):59-64. doi: 10.1007/s12254-018-0383-3. Epub 2018 Feb 21. Memo. 2018. PMID: 29606980 Free PMC article. Review.
Digital PCR in bone marrow trephine biopsies is highly sensitive for MYD88L265P detection in lymphomas with plasmacytic/plasmacytoid differentiation.
Willenbacher E, Willenbacher W, Wolf DG, Zelger B, Peschel I, Manzl C, Haun M, Brunner A. Willenbacher E, et al. Br J Haematol. 2019 Jul;186(1):189-191. doi: 10.1111/bjh.15792. Epub 2019 Feb 14. Br J Haematol. 2019. PMID: 30763982 No abstract available.
Towards Molecular Profiling in Multiple Myeloma: A Literature Review and Early Indications of Its Efficacy for Informing Treatment Strategies.
Willenbacher W, Seeber A, Steiner N, Willenbacher E, Gatalica Z, Swensen J, Kimbrough J, Vranic S. Willenbacher W, et al. Among authors: willenbacher e. Int J Mol Sci. 2018 Jul 18;19(7):2087. doi: 10.3390/ijms19072087. Int J Mol Sci. 2018. PMID: 30021955 Free PMC article. Review.
23 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback